Douglas SA - Search Results

1

A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670.

Douglas SA, Louden C, Vickery-Clark LM, Storer BL, Hart T, Feuerstein GZ, Elliott JD, Ohlstein EH. Douglas SA, et al. Circ Res. 1994 Jul;75(1):190-7. doi: 10.1161/01.res.75.1.190. Circ Res. 1994. PMID: 8013078

2

Regional vasodilation to endothelin-1 is mediated by a non-ETA receptor subtype in the anaesthetized rat: effect of BQ-123 on systemic haemodynamic responses.

Douglas SA, Elliott JD, Ohlstein EH. Douglas SA, et al. Eur J Pharmacol. 1992 Oct 20;221(2-3):315-24. doi: 10.1016/0014-2999(92)90718-j. Eur J Pharmacol. 1992. PMID: 1426008

3

Antihypertensive effects of the endothelin receptor antagonist BQ-123 in conscious spontaneously hypertensive rats.

Ohlstein EH, Douglas SA, Ezekiel M, Gellai M. Ohlstein EH, et al. Among authors: douglas sa. J Cardiovasc Pharmacol. 1993;22 Suppl 8:S321-4. doi: 10.1097/00005344-199322008-00084. J Cardiovasc Pharmacol. 1993. PMID: 7509976

4

Endothelin-1 promotes neointima formation after balloon angioplasty in the rat.

Douglas SA, Ohlstein EH. Douglas SA, et al. J Cardiovasc Pharmacol. 1993;22 Suppl 8:S371-3. doi: 10.1097/00005344-199322008-00097. J Cardiovasc Pharmacol. 1993. PMID: 7509990

5

Functional evidence that balloon angioplasty results in transient nitric oxide synthase induction.

Douglas SA, Vickery-Clark LM, Ohlstein EH. Douglas SA, et al. Eur J Pharmacol. 1994 Apr 1;255(1-3):81-9. doi: 10.1016/0014-2999(94)90085-x. Eur J Pharmacol. 1994. PMID: 7517884

6

Pharmacological evidence for the presence of three distinct functional endothelin receptor subtypes in the rabbit lateral saphenous vein.

Douglas SA, Beck GR Jr, Elliott JD, Ohlstein EH. Douglas SA, et al. Br J Pharmacol. 1995 Apr;114(8):1529-40. doi: 10.1111/j.1476-5381.1995.tb14936.x. Br J Pharmacol. 1995. PMID: 7599920 Free PMC article.

7

Selective ETA receptor antagonism with BQ-123 is insufficient to inhibit angioplasty induced neointima formation in the rat.

Douglas SA, Vickery-Clark LM, Louden C, Ohlstein EH. Douglas SA, et al. Cardiovasc Res. 1995 May;29(5):641-6. Cardiovasc Res. 1995. PMID: 7606751

8

Antihypertensive actions of the novel nonpeptide endothelin receptor antagonist SB 209670.

Douglas SA, Gellai M, Ezekiel M, Feuerstein GZ, Elliott JD, Ohlstein EH. Douglas SA, et al. Hypertension. 1995 Apr;25(4 Pt 2):818-22. doi: 10.1161/01.hyp.25.4.818. Hypertension. 1995. PMID: 7721437

9

In vivo pharmacological characterization of the non-peptide endothelin receptor antagonist SB 209670.

Douglas SA, Edwards RM, Elliott JD, Ohlstein EH. Douglas SA, et al. Br J Pharmacol. 1995 Jan;114(2):405-13. doi: 10.1111/j.1476-5381.1995.tb13241.x. Br J Pharmacol. 1995. PMID: 7881741 Free PMC article.

10

Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670.

Ohlstein EH, Beck GR Jr, Douglas SA, Nambi P, Lago MA, Gleason JG, Ruffolo RR Jr, Feuerstein G, Elliott JD. Ohlstein EH, et al. Among authors: douglas sa. J Pharmacol Exp Ther. 1994 Nov;271(2):762-8. J Pharmacol Exp Ther. 1994. PMID: 7965794

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters